Home
News Channels
Research & Development
News Channels
Research & Development
|
World Pharma News RSS Channel
Subscribe to World Pharma News by Email
Follow us on: |
Research & Development
Conferences & Events
- Safety Biomarkers in Drug Development Conference to be held in Bratislava, Slovak Republic
- 4th Annual Clinical Site Partnerships in Central & Eastern Europe, to be held in Budapest, Hungary
- Physicians Go Digital Across the Globe - Webinar May 19
- Emerging Superpowers of Clinical Research - Russia, India, China
Research & Development News Channel
Sponsored Ads |
Pharmaceutical CompaniesA | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | ZSponsored AdsPharmaceutical RSS NewsAbbott | Amgen | AstraZeneca | Boehringer Ingelheim | Bristol-Myers Squibb | Eli Lilly | GlaxoSmithKline | Janssen-Cilag | Johnson & Johnson | Novartis | Novo Nordisk | Pfizer | Roche | Shire | Takeda | ... European Commission - Pharmaceuticals US Food and Drug Administration Sponsored Ads
PharmaNews.eu, an advanced web based news engine, addressed to the European pharmaceutical domain, has been launched. The project was developed to directly connect, promote and disseminate the European pharmaceutical news...For further information and advanced RSS channels, please visit http://www.pharmanews.eu PharmaNews.eu / Latest News |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial
Product
- IRESSA (Gefitinib) Receives Marketing Authorisation in Europe
- AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
- Lundbeck receives FDA Complete Response Letter on Serdolect® for the treatment of schizophrenia
- New biological therapy Ilaris® approved in US
- Nycomed receives Marketing Authorization for Pantoprazole 20mg OTC from European Commission
Clinical Trials
- Lu AA24530 shows positive results in major depressive disorder phase II study
- Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa
- Pfizer Discontinues Phase 3 Trial of Sutent® in Metastatic Colorectal Cancer
- Sutent Significantly Improved Progression-Free Survival
- Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent
Corporate
- Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
- Bayer files patent infringement lawsuit against Teva
- Bayer Schering Pharma Extends Research Portfolio in the Field of Cancer-Related Targets
- Novo Nordisk reaches settlement with the Danish authorities regarding Oil-for-Food activities
- GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs
Pharmaceutical and healthcare market research company Manhattan Research releases its latest consumer marketing research module, "Online Adherence Programs: Evaluating Manufacturers' Opportunity to Impact Patient Adherence", as part of its Cybercitizen Health™ market research and strategic advisory service.
CAST PHARMA, a premier European 3D pharmaceutical and biomedical animation production company, is pleased to announce the availability of an advanced Demo-DVD to make its audiovisual material more widely available to the existing and further customers from the biomedical and pharmaceutical domains.
The European Food Safety Authority (EFSA), the European Centre for Disease Control and Prevention (ECDC) and the European Medicines Agency (EMEA) have published today a joint Scientific Report on meticillin resistant Staphylococcus aureus (MRSA) in livestock, pets and foods.
Results from the Rheumatoid Arthritis: Insights, Strategies & Expectations (RAISE) survey of more than 500 rheumatoid arthritis (RA) patients throughout Europe and Canada revealed a majority of patients still suffer from pain (79 percent), fatigue (67 percent) and joint stiffness (57 percent) on a regular basis despite current treatment, while more than half (51 percent) of RA patients feel their disease controls their life.
